Picton Mahoney Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-193,715
Closed -$13.5M 967
2024
Q3
$13.5M Buy
193,715
+26,815
+16% +$1.84M 0.44% 71
2024
Q2
$11.2M Sell
166,900
-33,100
-17% -$2.23M 0.44% 81
2024
Q1
$13.8M Buy
+200,000
New +$13.5M 0.41% 65
2023
Q2
Sell
-1,130
Closed -$62K 502
2023
Q1
$62K Sell
1,130
-5
-0.4% -$292 ﹤0.01% 382
2022
Q4
$71K Hold
1,135
﹤0.01% 539
2022
Q3
$80K Sell
1,135
-200
-15% -$13.8K ﹤0.01% 554
2022
Q2
$76K Sell
1,335
-910
-41% -$49.9K ﹤0.01% 654
2022
Q1
$140K Sell
2,245
-5,075
-69% -$274K 0.01% 674
2021
Q4
$410K Sell
7,320
-5,730
-44% -$350K 0.01% 658
2021
Q3
$849K Sell
13,050
-260
-2% -$17.7K 0.03% 560
2021
Q2
$844K Buy
+13,310
New +$786K 0.02% 577

Other funds holding AXNX

Picton Mahoney Asset Management's AXNX Position: Q4 2024 in Review

Picton Mahoney Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 193,715 shares — an estimated $13.5M sold.

Picton Mahoney Asset Management first reported a position in AXNX in Q2 2021 and held it in 11 quarters. The position peaked at $13.8M in Q1 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Picton Mahoney Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 193,715 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $13.5M.
  • Picton Mahoney Asset Management first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Picton Mahoney Asset Management's Axonics, Inc. Common Stock position peaked at $13.8M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.